新头痛方治疗紧张型头痛72例  

New Headache Prescription for Tension-type Headache:An Analysis of 72 Patients

作　　者：龙亚秋[1] 魏赈权 聂玲辉[2] 伍志勇[2] 陈宝田[2] 

机构地区：[1]广东省中医院芳村医院,广东广州510120 [2]南方医科大学南方医院,广东广州510515

出　　处：《安徽中医药大学学报》2016年第1期25-27,共3页Journal of Anhui University of Chinese Medicine

摘　　要：目的比较新头痛方与正天丸治疗紧张型头痛的临床疗效,以优化正天丸的组方。方法将132例紧张型头痛患者分为正天丸组60例和新头痛方组72例,疗程3个月,观察两组临床疗效以及治疗前后头痛发作程度、频率和持续时间。结果新头痛方组临床疗效明显优于正天丸组(P<0.05);与治疗前比较,两组治疗后头痛评分、发作频次、头痛持续时间均显著降低(P<0.05);新头痛方组治疗后发作频次降低程度显著大于正天丸组(P<0.05)。结论新头痛方治疗紧张型头痛的临床疗效优于正天丸。Objective To compare the clinical efficacy between New Headache Prescription and Zhengtian Pill in the treatment of tension-type headache, and to optimize the prescription of Zhengtian Pill. Methods One hundred and thirty-two patients with tension-type headache were randomly divided into Zhengtian Pill group （n=60） and New Headache Prescription group （n=72）. The treatment lasted for three months. The clinical outcomes and changes in the degree, frequency, and duration of headache after treatment were evaluated in both groups. Results The New Headache Prescription group had significantly better clinical outcomes than the Zhengtian Pill group （P〈0.05）. Both groups had significantly reduced score, frequency, and duration of headache after treatment （P〈0.05）. The New Headache Prescription group had a significantly larger decrease in the frequency of headache than the Zhengtian Pill group （P〈0.05）. Conclusion New Headache Prescription has superior clinical efficacy over Zhengtian Pill in the treatment of tension type headache.

关 键 词：新头痛方 正天丸 紧张型头痛 

分 类 号：R747.2[医药卫生—神经病学与精神病学]